- Home
- Equipment
- usa maryland
- transplanter
Show results for
Refine by
Transplanter Equipment Supplied In Usa Maryland
6 equipment items found
Manufactured by:United Therapeutics Corporation based inSilver Spring, MARYLAND (USA)
Miromatrix is developing bioengineered organs for transplantation, and our technology can be applied across the spectrum of donor needs. We are currently focused on bioengineering transplantable kidneys (MiroKidney) and livers (MiroLiver), but we believe our technology can be used to engineer other in-demand organs, such as lungs, pancreases, hearts and other ...
by:Gain Therapeutics, Inc. based inBethesda, MARYLAND (USA)
Very limited and investigational symptomatic treatment options include substrate reduction therapy, enzyme replacement therapy, bone marrow transplantation, stem cell transplantation and gene therapy to address non-CNS symptoms. Gain is developing allosteric regulators that are designed to decrease toxic substrate accumulation in organs and tissues of patients ...
by:Gain Therapeutics, Inc. based inBethesda, MARYLAND (USA)
Very limited and investigational symptomatic treatment options include substrate reduction therapy, enzyme replacement therapy, bone marrow transplantation, stem cell transplantation and gene therapy to address non-CNS symptoms. Gain is developing allosteric regulators that are designed to decrease toxic substrate accumulation in organs and tissues of patients ...
Manufactured by:Tonix Pharmaceuticals Holding Corp. based inChatham, NEW JERSEY (USA)
TNX-1500 incorporates the antigen binding fragment (Fab) region of hu5c8 (recombinant monoclonal antibody to CD40-ligand), that has been extensively characterized at the molecular level in complex with the CD40-ligand. TNX-1500 is being studied and evaluated for its role in preventing or treating organ transplant rejection and for treating autoimmune ...
by:Gain Therapeutics, Inc. based inBethesda, MARYLAND (USA)
There is currently no cure for these patients; however, enzyme replacement therapy and hematopoietic stem cell transplant are used to manage the non-CNS symptoms. Gain is developing allosteric regulators to increase IDUA activity and decrease toxic sugar accumulation in the CNS of patients with MPS 1 to potentially become the first treatment for the disease’s neuronopathic ...
Manufactured by:United Therapeutics Corporation based inSilver Spring, MARYLAND (USA)
Perfusion recellularization begins with organ scaffolds created by perfusion decellularization. These scaffolds are capable of receiving and incorporating a variety of cell types, depending on the organ scaffold utilized. Perfusion decellularization enables organ scaffolds to retain their native vasculature and so cells are introduced through existing vascular ...